Omburtamab I-131 Available Phase N/A Trials for Central Nervous System/Leptomeningeal Neoplasms

IndicationsStatusPurposePhase
AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT05064306131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults